Hangzhou AGS Medtech(688581.SH) granted 391,500 restricted shares at a price of 70 yuan per share.
Hangzhou AGS Medtech(688581.SH) announcement, the restrictive stock grant conditions stipulated in the company's 2023 restricted stock incentive plan have been achieved. The company has determined September 7, 2023 as the initial grant date for the restricted stocks of this equity incentive plan. It will grant 391,500 restricted stocks at a price of 70 yuan per share to 69 eligible incentive recipients.
Related Articles

SoftBank-backed PayPay (PAYP.US) IPO priced at $16, below the previously recommended range.

US Stock Market Move | Encrypting mining companies have increased their gains, IREN (IREN.US) up nearly 7%

Evening hot topic in A-shares | The People's Bank of China speaks out! Actively and prudently, safely and orderly promoting the application of artificial intelligence in the financial field.
SoftBank-backed PayPay (PAYP.US) IPO priced at $16, below the previously recommended range.

US Stock Market Move | Encrypting mining companies have increased their gains, IREN (IREN.US) up nearly 7%

Evening hot topic in A-shares | The People's Bank of China speaks out! Actively and prudently, safely and orderly promoting the application of artificial intelligence in the financial field.

RECOMMEND

“A+H” Team Continues To Expand Hard Technology Firms Accelerate Global Deployment
11/03/2026

Anti‑Stagflation Theme Guides Hong Kong Allocation Institutions Identify Power And Energy Assets As Short‑Term Core
11/03/2026

U.S. Equities Enter “Always‑On” Trading Era Nasdaq Advances Stock Tokenization Framework
11/03/2026


